Company Financials

KPC Pharmaceuticals, Inc. Financials

Renminbi

business KPC Pharmaceuticals, Inc. Company Profile

Main Stock Listing

SSE: 600422

Market Capitalization CN¥11.99 Billion as of Jan. 1, 2025

Market Cap History

Valuations Metrics as of Jan. 25, 2025

Trailing PE 26.85
Forward PE 16.85
Price to Sales TTM CN¥1.59
Price to Book MRQ CN¥2.17
Enterprise to Revenue 1.41
Enterprise to EBITDA 16.38

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2024-09-30
Profit Margin 5.91%
Operating Margin 15.21%
Return on Assets TTM 3.24%
Return on Equity TTM 8.06%

Income Statement

Revenue TTM CN¥7,549,712,384
Revenue per Share TTM CN¥10.03
Quarterly Revenue Growth 3.40%
Gross Profit TTM CN¥3,452,540,747
EBITDA CN¥735,550,721
Net Income to Common TTM CN¥446,068,224
Diluted EPS TTM CN¥0.59
Quarterly Earnings Growth YoY -2.90%

Balance Sheet

Total Cash MRQ CN¥2,012,550,912
Total Cash per Share MRQ CN¥2.66
Total Debt MRQ CN¥
Total Debt to Equity MRQ 14.25
Current Ratio MRQ 1.91
Book Value per Share MRQ CN¥7.31

Cash Flow

Operating Cash Flow TTM CN¥608,796,096
Levered Free Cash Flow TTM CN¥476,122,560

600422 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding 756,976,000
Float Shares 461,847,109
Avg 10 Volume 10,619,535
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 37.68%
% Held by Institutions 19.65%

Stock Price Summary

Beta 0.22
Fifty Two Week Low CN¥11.92
Fifty Two Week High CN¥24.11
Fifty Two Week Change -20.04%
Day 50 MA CN¥14.85
Day 200 MA CN¥17.63

Dividends and Splits

Forward Annual Dividend Rate CN¥0.80
Forward Annual Dividend Yield 4.95%
Trailing Annual Dividend Rate CN¥0.20
Trailing Annual Dividend Yield 1.24%
Payout Ratio 33.76%
Dividend Date
Ex Dividend Date 2024-07-31
Last Split Factor
Last Split Date 2016-05-09